The giant titin: how to evaluate its role in cardiomyopathies

11Citations
Citations of this article
48Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Titin, the largest protein known, has attracted a lot of interest in the cardiovascular field in recent years, since the discovery that truncating variants in titin are commonly found in patients with dilated cardiomyopathy. This review will discuss the contribution of variants in titin to inherited cardiac conditions (cardiomyopathies) and how model systems, such as animals and cellular systems, can help to provide insights into underlying disease mechanisms. It will also give an outlook onto exciting technological developments, such as in the field of CRISPR, which may facilitate future research on titin variants and their contributions to cardiomyopathies.

Cite

CITATION STYLE

APA

Azad, A., Poloni, G., Sontayananon, N., Jiang, H., & Gehmlich, K. (2019). The giant titin: how to evaluate its role in cardiomyopathies. Journal of Muscle Research and Cell Motility, 40(2), 159–167. https://doi.org/10.1007/s10974-019-09518-w

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free